Cigna Group (NYSE:CI) Stock Price Target Lowered at Guggenheim

Cigna Group (NYSE:CI) had its price objective lowered by Guggenheim from $361.00 to $347.00 in a research report report published on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the health services provider’s stock.

Several other brokerages have also weighed in on CI. Barclays increased their price objective on Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Cigna Group in a research note on Friday, October 2nd. Robert W. Baird set a $362.00 price objective on shares of Cigna Group in a report on Friday, July 31st. Wells Fargo & Company upped their target price on shares of Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $340.00 target price on shares of Cigna Group in a research note on Friday. Fourteen investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $335.70.

Cigna Group Trading Down 2.6%

Cigna Group stock traded down $7.82 during trading on Friday, reaching $293.66. 2,427,984 shares of the company were exchanged, compared to its average volume of 1,441,425. The stock’s 50 day simple moving average is $285.81 and its two-hundred day simple moving average is $282.17. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The company has a market capitalization of $77.60 billion, a P/E ratio of 12.96, a PEG ratio of 1.00 and a beta of 0.25. Cigna Group has a 52-week low of $255.53 and a 52-week high of $318.05.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, November 5th. The health services provider reported $7.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.52 by $0.46. The firm had revenue of $73.79 billion during the quarter, compared to analysts’ expectations of $72.64 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. Cigna Group’s revenue was up 5.6% compared to the same quarter last year. During the same period last year, the business earned $7.83 earnings per share. On average, equities research analysts expect that Cigna Group will post 30.52 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 17th. Shareholders of record on Thursday, December 3rd will be paid a dividend of $1.56 per share. The ex-dividend date is Thursday, December 3rd. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. Cigna Group’s dividend payout ratio is 25.82%.

Insider Activity

In other news, insider Everett Neville sold 617 shares of the firm’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the transaction, the insider owned 5,053 shares of the company’s stock, valued at approximately $1,435,304.65. This trade represents a 10.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 2,677 shares of Cigna Group stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the transaction, the insider owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This trade represents a 9.37% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Cigna Group

Institutional investors have recently modified their holdings of the business. McKinney Capital Management LLC purchased a new stake in shares of Cigna Group during the third quarter worth approximately $1,373,000. Diversified Trust Co grew its holdings in Cigna Group by 42.1% during the 3rd quarter. Diversified Trust Co now owns 4,429 shares of the health services provider’s stock worth $1,204,000 after acquiring an additional 1,313 shares in the last quarter. Vista Capital Partners Inc. acquired a new position in Cigna Group during the 3rd quarter worth approximately $332,000. Aberdeen Group plc lifted its holdings in Cigna Group by 389.6% during the 3rd quarter. Aberdeen Group plc now owns 1,078,857 shares of the health services provider’s stock worth $283,907,000 after buying an additional 858,488 shares during the last quarter. Finally, Allworth Financial LP lifted its holdings in Cigna Group by 7.5% during the 3rd quarter. Allworth Financial LP now owns 34,925 shares of the health services provider’s stock worth $9,628,000 after buying an additional 2,444 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

More Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Third-quarter adjusted earnings were $7.98 per share, ahead of estimates, while revenue rose 6% to about $73.8 billion and also exceeded consensus. Strength in Cigna Healthcare and a favorable pharmacy benefit mix supported results. Cigna Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $30.60 per share. Employer medical growth is expected to help offset Cigna’s exit from the ACA individual market. Cigna lifts 2026 outlook
• Positive Sentiment: At its investor event, Cigna outlined a multi-year $3 billion modernization and productivity program, targeting 10%–14% adjusted EPS growth annually and approximately $50 billion in cumulative operating cash flow through 2030. Cigna raises 2026 outlook after strong quarter
• Neutral Sentiment: Analyst views remain supportive: Cantor Fitzgerald reaffirmed Overweight with a $340 target. Guggenheim kept a Buy rating but lowered its target to $347 from $361, tempering the positive signal. Guggenheim ratings
• Negative Sentiment: Despite higher adjusted earnings, reported GAAP net income fell to $1.4 billion from $1.87 billion a year earlier. The ACA individual-market exit also brings transition and execution risks, even as employer business growth is expected to offset it. Cigna Group lifts outlook as revenue climbs

About Cigna Group

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members.

Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

The company serves customers in the United States and select international markets.